Skip to main content
. 2020 Nov 17;11:581673. doi: 10.3389/fimmu.2020.581673

Figure 5.

Figure 5

Apremilast attenuated the EAU via the PI3K/AKT/FoxO1 signaling pathway. (A–I) CD4+ T-lymphocytes from the DLNs of the EAU group induced by IRBP1-20 for 3 days with or without apremilast treatment were analyzed; the proportion and population of pPI3K+, pAKT+, and pFoxO1+. (J–L) The frequency and number of FoxO1+ CD4+ T-cells with or without apremilast treatment. Data expressed as mean±SD, **P < 0.01, ***P < 0.001, N = 6.